Journal Article Review Epublish 16 citations
PubMed: 38004261 DOI: 10.3390/life13112121
Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response.
Life (Basel) 13(11)
Authors: Aditi Mohan, Venkatesh Anand Iyer, Dharmender Kumar, Lalit Batra, Praveen Dahiya
Affiliations
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida Sector-125, Noida 201313, Uttar Pradesh, India.
- Department of Biotechnology, Deenbandhu Chhotu Ram University of Science &Technology, Murthal, Sonipat 131309, Haryana, India.
- Regional Biocontainment Laboratory, Center for Predictive Medicine, University of Louisville, Louisville, KY 40222, USA.
Abstract
The COVID-19 pandemic has affected the world unprecedentedly, with both positive and negative impacts. COVID-19 significantly impacted the immune system, and understanding the immunological consequences of COVID-19 is essential for developing effective treatment strategies. The purpose of this review is to comprehensively explore and provide insights into the immunological aspects of long COVID-19, a phenomenon where individuals continue to experience a range of symptoms and complications, even after the acute phase of COVID-19 infection has subsided. The immune system responds to the initial infection by producing various immune cells and molecules, including antibodies, T cells, and cytokines. However, in some patients, this immune response becomes dysregulated, leading to chronic inflammation and persistent symptoms. Long COVID-19 encompasses diverse persistent symptoms affecting multiple organ systems, including the respiratory, cardiovascular, neurological, and gastrointestinal systems. In the post-COVID-19 immunological era, long COVID-19 and its impact on immune response have become a significant concern. Post-COVID-19 immune pathology, including autoimmunity and immune-mediated disorders, has also been reported in some patients. This review provides an overview of the current understanding of long COVID-19, its relationship to immunological responses, and the impact of post-COVID-19 immune pathology on patient outcomes. Additionally, the review addresses the current and potential treatments for long COVID-19, including immunomodulatory therapies, rehabilitation programs, and mental health support, all of which aim to improve the quality of life for individuals with long COVID-19. Understanding the complex interplay between the immune system and long COVID-19 is crucial for developing targeted therapeutic strategies and providing optimal care in the post-COVID-19 era.
MeSH
Immunity, Immune System, Infections, Autoimmunity, Pathology, Cells, Therapeutics, Post-Acute Covid-19 Syndrome
Cited by
- Nanoparticles of natural product-derived medicines: Beyond the pandemic. Heliyon, 2025
- Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals. Infect Immun, 2024
- Immune Dysregulation in HIV and COVID-19 Co-infection: Therapeutic Implications. Immun Inflamm Dis, 2025
- The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status. Iran J Med Sci, 2025
- Long-Term Effects of COVID-19 on Women's Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis. J Clin Med, 2025